Profilo
Xavier Avat, former Head of Corporate Development at Gilead Sciences, Inc., served as the SVP of Global Corporate Strategy & New Initiatives at Edwards Lifesciences Corp.
He also held the position of Vice President of Corporate Development at Santen Pharmaceutical Co., Ltd.
In 2022-2023, Avat worked as the Chief Business Officer at Capricor Therapeutics, Inc. Avat graduated from Ecole Polytechnique Universitaire de Lille and holds an MBA from École des Hautes Études Commerciales du Nord.
Precedenti posizioni note di Xavier Avat
Società | Posizione | Fine |
---|---|---|
CAPRICOR THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2023 |
GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
SANTEN PHARMACEUTICAL CO., LTD. | Corporate Officer/Principal | - |
EDWARDS LIFESCIENCES CORPORATION | Corporate Officer/Principal | - |
Formazione di Xavier Avat
École des Hautes Études Commerciales du Nord | Masters Business Admin |
Ecole Polytechnique Universitaire de Lille | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 4 |
---|---|
CAPRICOR THERAPEUTICS, INC. | Health Technology |
EDWARDS LIFESCIENCES CORPORATION | Health Technology |
SANTEN PHARMACEUTICAL CO., LTD. | Health Technology |
GILEAD SCIENCES, INC. | Health Technology |
- Borsa valori
- Insiders
- Xavier Avat